Hippo Holdings (HIPO)
(Delayed Data from NYSE)
$17.29 USD
+0.82 (4.98%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $17.29 0.00 (0.00%) 5:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$17.29 USD
+0.82 (4.98%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $17.29 0.00 (0.00%) 5:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
Zacks News
Oscar Health, Inc. (OSCR) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Oscar Health, Inc. (OSCR) delivered earnings and revenue surprises of -19.74% and 5.08%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Horace Mann (HMN) Q3 Earnings Beat Estimates
by Zacks Equity Research
Horace Mann (HMN) delivered earnings and revenue surprises of 17.86% and 2.52%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Kemper (KMPR) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Kemper (KMPR) delivered earnings and revenue surprises of -11.63% and 0.65%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Assurant (AIZ) Q3 Earnings Beat Estimates
by Zacks Equity Research
Assurant (AIZ) delivered earnings and revenue surprises of 1% and 1.81%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Things to Know Ahead of Lincoln National's (LNC) Q3 Earnings
by Zacks Equity Research
Lincoln National's (LNC) Q3 results are likely to reflect strength in the Group Protection segment and cost-cutting measures, partly offset by a declining net investment income.
Can High Catastrophe Losses Hurt Allstate's (ALL) Q3 Earnings?
by Zacks Equity Research
Allstate's (ALL) Q3 results are likely to suffer Hurricane Ian-induced catastrophe losses and inflationary pressures, partly offset by growing premiums within its Property-Liability segment.
Hippo Holdings Inc. (HIPO) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Hippo Holdings Inc. (HIPO) delivered earnings and revenue surprises of -30% and 7.42%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
OTC Markets Group Inc. (OTCM) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
OTC Markets Group Inc. (OTCM) delivered earnings and revenue surprises of 1.67% and 2.28%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Lemonade (LMND) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lemonade (LMND) delivered earnings and revenue surprises of 19.12% and 5.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Great Ajax (AJX) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Great Ajax (AJX) delivered earnings and revenue surprises of -16.67% and 15.81%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
MGIC Investment (MTG) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
MGIC (MTG) delivered earnings and revenue surprises of 50% and 2.66%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Hippo Holdings Inc. (HIPO) Is a Great 'Buy the Bottom' Stock Now
by Zacks Equity Research
Hippo Holdings Inc. (HIPO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Hippo Holdings Inc. (HIPO) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
by Zacks Equity Research
Hippo Holdings Inc. (HIPO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.